The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing ...
DUBLIN--(BUSINESS WIRE)--The "In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules" report has been added to ResearchAndMarkets.com's offering. This report features an ...